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Background and Aims: Arsenic trioxide (As2O3) can induce clinical remission in patients 
suffering from acute promyelocytic leukemia, through induction of apoptosis and activation 
of caspases. We investigated the potential use of As2O3 in human gastric cancer and its 
possible mechanisms.  Methods: Human gastric cancer cell lines AGS and MKN-28 were 
treated with various concentrations (0.1 to 100 μM) of As2O3 for 24-72 hours. Apoptosis was 
determined by acridine orange staining, flow cytometry and DNA fragmentation. The protein 
levels of p53, p21waf1/cip1, c-myc, bcl-2 and bax were detected by Western blotting. Effects of 
As2O3 on caspase 3 protease activity, its protein concentration and cleavage of poly-ADP 
ribose polymerase (PARP) were also studied. Results: Triptolide inhibited cell growth and 
induced apoptosis in both cell lines, although AGS cells were more sensitive. As2O3 induced 
apoptosis in AGS cells following a concentration- and time-dependent manner. Treatment 
resulted in a marked increase in p53 protein level as early as 4 hours. Co-incubation with p53 
anti-sense oligo-nucleotide suppressed As2O3-induced intracellular p53 over-expression and 
apoptosis. As2O3 increased the activity of caspase 3, with appearance of its p17-kD peptide 
fragment, and cleavage of PARP with appearance of the 85-kD cleavage product, both in 
parallel with the induction of apoptosis. The tripeptide caspase inhibitor zVAD-fmk or the 
specific caspase 3 inhibitor DEVD-fmk both partially suppressed As2O3-induced caspase 3 
activation and apoptosis. Conclusions: As2O3 inhibits cell growth and induces apoptosis in 
gastric cancer cells, involving p53 overexpression and activation of caspase 3. The potential 
use of this compound in treatment of gastric cancer is worth further investigation. 
 
Introduction 
Comment [D1]:  
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Recently it has been shown that arsenic compounds, including the inorganic arsenic 
trioxide (As2O3) and arsenic disulfide, are effective for the treatment of patients with acute 
promyelocytic leukemia (APL) (Sun HD et al, 1992; Huang SL et al, 1995). Arsenic-
containing compounds have been used in traditional Chinese medicine for many years. No 
significant bone marrow suppression was observed in most patients following administration 
of As2O3 (Shen ZX et al, 1997).  In a study of fifteen patients with APL, none of those 
receiving arsenic alone developed significant thrombocytopenia or anemia. Among those who 
received arsenic with standard chemotherapy, only slight decrease in platelet and hemoglobin 
level was observed (Shen ZX et al, 1997).  Recently the clinical efficacy of As2O3 in APL has 
been confirmed even in patients resistant to conventional chemotherapy (Soignet SL et al, 
1998).  In vitro studies on the molecular mechanism of As2O3 on APL cells showed that the 
inhibition on cell proliferation was due to a direct induction of apoptosis through down-
regulation of bcl-2 expression and modulation of PML/RARα/PML protein (Chen GQ et al, 
1996). Furthermore, the activation of caspases was also involved in As2O3-induced apoptosis 
in APL cells (Shen ZX et al, 1997).   The apoptotic effect of As2O3 can be observed in various 
cell lines of either myeloid or lymphoid origin (Soignet S et al, 1996; Ishitsuka K et al, 1997).  
Wang et al reported that As2O3 and melarsoprol, the organic arsenical, induced apoptosis in 
myeloid leukemia cell lines such as HL-60, U937 and KG-1 through down-regulation of Bcl-2 
protein (Wang ZG et al, 1998).  Akao et al also showed that As2O3 induced apoptosis through 
activation of caspases in B-cell leukemia cell lines (Akao Y et al, 1998). This raised the 
interest of looking at its apoptotic effect in other tumors, including esophageal cancer, 
neuroblastoma, head and neck cancers, and cervical cancers (Shen ZY et al,1999; Akao Y et 
al,1999; Seol JG et al,1999; Zheng J et al,1999). Two studies using As2O3 against six and 
seventeen human cancer cell lines respectively found that the most marked effects were seen 
in bladder cancer, APL and gastrointestinal cancer cells, including the human gastric cancer 
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cell line MGC-803 (Zhang TC et al, 1999; Yang CH et al, 1999). 
       It has been shown that tumors develop not only from abnormal cell proliferation, but also 
from reduced cell death due to inhibition of apoptosis. (Bergamaschi G et al, 1994) The 
possibility of modulating apoptosis of tumor cells suggests new strategies for improving 
chemotherapy. (Steller H et al, 1996)  Apoptosis is regulated by gene products, which are 
conserved from nematodes to mammals (Penninger JM et al, 1998).  Among all apoptosis-
related genes, p53 is of particular importance. (Lowe SW et al, 1993) P53 is well known for 
suppression of cellular proliferation through two mechanisms, each operating in a distinct 
manner. In normal fibroblasts, p53 induces G1 arrest in response to DNA-damaging agents, 
presumably allowing the cells to perform critical repair functions before progressing through 
the cell cycle (Linke SP et al, 1997).   On the other hand, in abnormally proliferating cells or 
irradiated thymocytes, induction of p53 leads to apoptosis (Midgley CA et al, 1995).  
Furthermore, wild-type p53 protein level was increased during apoptosis induced by DNA-
damaging agents (Zhan Q et al, 1996). The increased expression of wild type p53 can induce 
apoptosis in myeloid leukemia and colon cancers (Yonish-rouach E et al, 1991; Shaw P et al, 
1992). Recently, changes of DNA methylation in the p53 gene promoter induced by arsenic 
treatment have been shown in cultured human lung cells, which indicated p53 could be a 
target of arsenic (Mass MJ et al, 1997).  On the contrary, arsenic treatment in JB6 cell lines 
did not induce p53-dependent transactivation (Huang CS et al, 1999).   This may indicate that 
the response or involvement of p53 in apoptosis is cell type specific. Our previous studies 
showed that indomethacin induced apoptosis in AGS gastric cancer cells without induction of 
p53 mRNA and protein level while protein kinase C inhibitors induced apoptosis in the same 
cells with increase in p53 protein level (Zhu GH et al, 1999a, 1999b, 1999c).  
Members of the caspase family play key roles in the execution phase of apoptosis 
(Cohen GM et al, 1997).  These cysteine proteases are synthesized as inactive proenzymes 
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which are activated by different apoptotic stimuli, leading to specific cleavage of a range of 
cellular protein substrates (Alnemri ES et al, 1997). These substrates include enzymes that are 
involved in genome surveillance and DNA repair such as poly ADP-ribose polymerase 
(PARP).  Among the family of ten or more different caspases already described, caspase 3 is a 
major effector of apoptosis. Caspase 3 is activated in a variety of cell types during apoptosis 
including As2O3-treated leukemia cell lines (Soignet SL et al, 1998; Schlegel J et al, 1996; 
Datta R et al, 1996).  The importance of caspase 3 has been further confirmed by the study that 
caspase 3 knockout mice suffered from severe developmental abnormalities attributed to the 
disturbed regulation of apoptosis (Kueda K et al, 1996).   
     In this study, we showed that As2O3 is a potent inducer of apoptosis in AGS cells. The 
apoptosis is associated with upregulation of p53 and a rapid activation of caspase 3 protease, 
with the proteolytic degradation of PARP. Our results suggest that both p53 and caspase 3 are 
involved in apoptotic cell death induced by arsenic trioxide in gastric cancer. 
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Materials and Methods 
Drugs  
0.1% As2O3 solution for intravenous administration was kindly provided by the Pharmacy of 
Chinese Traditional Medicine in the First Hospital affiliated to Harbin Medical University 
(Harbin, People’s Republic of China). Stock solutions were made at the concentration of 1 
mmol/L with phosphate-buffered saline (PBS) and diluted to working concentrations before 
use.  
Cell Culture and As2O3 Treatment  
AGS, a gastric adenocarcinoma cell line bearing wild-type p53, was purchased from the 
American Type Culture Collection (ATCC, Rockville, MD, USA). MKN-28, a gastric  
adenocarcinoma cell line, does not contain wild-type p53, but has missense mutation (codon 
251, isoleucine to leucine (Matozaki T et al, 1992). This was kindly donated by Professor SD 
Xiao ( Shanghai Second Medical University). Cells were cultured in RPMI-1640 medium 
supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml 
streptomycin (Gibco BRL, Life Technologies, NY, USA) in a humidified atmosphere of 95% 
air with 5% CO2 at 370C as a monolayer. The cells were seeded 24h before drug treatment and 
were 60-70% confluent at the time of treatment. Different concentrations of As2O3 (0.1μM to 
100μM) were added to the medium for different time period. After treatment, adherent cells 
were removed by trypsinization and combined with floating cells in the medium for further 
analysis. 
MTT Assay  
Cell growth was measured by a modified MTT assay (Boehringer Mannheim, BMGH, 
Germany) (Carmichael J et al, 1985). About 8,000 cells per well were grown in 96-well plates 
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and incubated overnight in 100 μl of culture medium. Then cells were treated with different 
concentrations of As2O3 for fixed time intervals. Ten μl MTT labeling reagent (final 
concentration 0.5mg/ml) was added to each well, and the cells were further incubated at 370C 
for 4 hours. The supernatant was removed and 100μl of 0.04 M hydrochloric acid in 
isopropanol was added to each well. A micro ELISA reader (BioRad, CA, USA) was used to 
measure the absorbency at a wavelength of 595 nm. The blank control contained the cell 
culture medium only. Each assay was performed three times in triplicates. 
Acridine Orange Staining  
Single cell suspensions were fixed in 1% formalin/ PBS and stained with acridine orange 
(AO, 10 μg/ml, Sigma, St. Louis, USA). Cells were spotted on glass slides and visualized 
under fluorescence microscope. Apoptotic cells were defined as cells showing cytoplasmic 
and nuclear shrinkage and chromatin condensation or fragmentation morphologically. At least 
300-cells/ field were counted to determine the apoptotic index. 
 
Flow cytometry  
Cells were collected and fixed in ice-cold 70% ethanol in PBS and stored at -200C before use. 
After resuspension, cells were washed and incubated with 100 μl of RNAase I (1mg ml-1) and 
100 μl of propidium iodide (PI, 400 μg/ml, Sigma) at 370C for 30 min. The analysis of 
samples was performed by a flow cytometry (Coulter Epics XL, UK). The cell cycle phase 
distribution was calculated from the resultant DNA histogram using Multicycle AV software 
(Phoenix Flow System, San Diego, CA, USA). The apoptotic cells can be observed as a 
subdiploid or ‘pre-G1’ peak on the DNA histogram. 
 
DNA Fragmentation Analysis  
DNA fragmentation was analyzed as described previously (Grant S et al, 1992) with some 
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modification. Briefly, cells were harvested and rinsed twice in ice-cold PBS. The final pellets 
were lysed in 0.3 ml 10 mM Tris-HCl (pH7.4) buffer containing 25 mM EDTA, 0.5% SDS and 
0.1mg/ml proteinase K (Sigma, St. Louis, USA) and incubated at 500C for 12-18 hours.  DNA 
was extracted with an equal volume of phenol/chloroform/isoamyl alcohol (25:24:1) and 
precipitated with two volumes of ice-cold absolute ethanol and 1/10 volume 3M sodium 
acetate. DNA was collected, washed once with 70% ethanol, and dissolved in TE buffer (10 
mM Tris and 1 mM EDTA, pH 8.0). The samples were incubated with 10 μg/ml RNase I for 1 
hour at 370C. Equal amounts (10μg per well) of DNA was electrophoresed in 1.8% agarose 
gels impregnated with ethidium bromide (0.1μg/ml) for 2 hours at 80V. DNA fragments in the 
form of laddering pattern were visualized by ultraviolet transillumination. 
Western Blotting  
After treatment, the whole cell lysates were extracted with lysis buffer containing 1% Triton-
100, 50 mM sodium chloride, 50 mM sodium fluoride, 20 mM Tris (pH7.4), 1 mM EDTA, 1 
mM EGTA, 1 mM sodium vanadate, 0.2 mM phenymethylsulfonyl floride and 0.5% Nonidet 
P-40. The protein concentration was determined by using Bicinchoninic acid assay (BCA)( 
Smith PK et al, 1985) with bovine serum albumin (Sigma, St. Louis, USA) as standard. 
Western blotting was carried out as described previously (Li Y et al, 1996). In brief, equal 
amount of cell lysates (60μg) were solublized in 10% sodium dodecyl sulphate polyacrylamide 
gel electrophoresis (SDS-PAGE) and transferred onto nitrocellulose membranes (Sigma, St. 
Louis, USA). After blocking, the membranes were incubated with the appropriate diluted 
primary antibody. Then membranes were incubated with a horseradish peroxidase-conjugated 
secondary antibody. Proteins were detected by the enhanced chemiluminescence (ECL) 
detection system (Amersham, Buckinghamshire, England). Mouse monoclonal antibodies 
against p53 (Ab-6), p21waf1/cip1 (Ab-1), c-myc (Ab-1) and peroxidase-conjugated anti-mouse 
IgG were purchased from Oncogene Research Products (CalBiochem, La Jolla, CA, USA). 
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Monoclonal antibodies against bcl-2 (100) and bax (B-9) were purchased from Santa-Cruz 
Biotechnology (CA, USA). Rabbit polyclonal antibody against cpp-32 and mouse monoclonal 
antibody against PARP (c-20) were purchased from Pharmingen (San Diego, CA, USA). 
Caspase 3 Activity Assay  
Caspase 3 activity was determined using the Clontech ApoAlert CPP32 Assay Kit according 
to the manufacturer’s instructions (Clontech, Palo Alto, CA). These assays depended upon the 
cleavage of a specific colorimetric caspase substrate, DEVD-ρNA (Asp-glu-val-asp-ρ-
nitroanilide). Cells were plated into 60mm dishes at 2×106cells/dish and cultured for 24 hours 
before treatment. After treatment, cells were collected by scraping in cold PBS, centrifuged 
(2000rpm, 8min) and lysed in the Cell Lysis Buffer provided in the kit on ice for 10 min. The 
extracts were frozen and maintained at -700C until the time of assay. At that time, the extracts 
were thawed and reacted with an equal volume of 2×Reaction Buffer containing DTT (10mM) 
and the colorimetric caspase-3 substrate (DEVD-ρNA). The mixtures were maintained in a 
water bath at 370C for 45 min and then analyzed in a spectrophotometer at 405nm.  
 
Statistical Analysis  
The data shown were mean values of at least three different experiments and expressed as 
means±S.D. Student’s t-test was used to compare the result. A p-value of less than 0.05 is 
considered statistically significant. 
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Results 
Effect of As2O3 on Cell Growth  
We examined the antiproliferative effect of As2O3 on human gastric cancer cell lines AGS and 
MKN-28 by exposing them to different concentrations of As2O3 for 24 to 72hrs. Cell viability 
was determined by MTT assay. When AGS and MKN-28 cells were exposed to As2O3 
ranging from 0.1μM to 100μM, the growth of both cell lines was inhibited in a dose 
dependent manner.  However, AGS cells were much more sensitive to growth inhibition by 
As2O3 than MKN-28 cells (data not shown). 
 
Apoptosis of Gastric Cancer Cells Induced by As2O3  
Morphological changes typical of apoptosis, including chromatin condensation, fragmentation 
of the nuclei, and formation of apoptotic bodies were observed in AGS cells after 12 hours 
with the concentration of more than 1 μM (Figure 1). The percentage of apoptotic cells 
increased in a time- and dose-dependent manner. Approximately 25% of the AGS cells 
underwent apoptosis with treatment of 10 μM As2O3 for 24 hours. However, only about 4.8% 
MKN-28 cells died after 24 hours treatment with the same concentration (data not shown). 
Apoptosis was further confirmed by agarose gel electrophoresis of the genomic DNA. A 
characteristic pattern of nucleosomal-sized ladders of DNA fragments, which characterized 
programmed cell death, was detected after 24 hours exposure to As2O3 (1μM, 10μM) in AGS 
cells (Figure 2). FACS analysis showed that As2O3 could induce apoptosis in AGS cells, with 
a typical sub-diploid peak on the DNA histogram (Figure 3). Taken together, these results 
demonstrated that AGS cells, which contained wild type p53, were more sensitive to As2O3-
induced apoptosis than MKN-28 cells.  
Effects of As2O3 on the cell cycle phase distribution  
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To investigate the antiproliferative mechanisms of As2O3, the cell cycle phase distribution of 
AGS cells treated with different concentrations of As2O3 were analyzed by flow cytometry. 
The results showed that after the indicated treatments for 24 hours, there was no obvious 
alteration of each cell cycle phase when compared with the control (Figure 3). 
 
Effects of As2O3 on p53, p21waf1/cip1, c-myc, bcl-2 and bax Protein Levels 
To further evaluate the mechanism of As2O3-induced apoptosis in gastric cancer, we examined 
the changes in protein expression of apoptotic-related genes including p53, p21waf1/cip1, c-myc, 
bcl-2 and bax. Treatment with 1 μM As2O3 resulted in a marked increase in p53 protein level 
noted as early as 4 hours and reached a maximum at 24 hours which was approximately 3 
times that of the control (Figure 4). However, there were no apparent changes of protein levels 
in other apoptosis-related genes, i.e. p21waf1/cip1, c-myc, bcl-2 and bax during the course of 
treatment (Figure 4). In contrast, in MKN-28 cells there was no detectable change of these 
apoptotic-related genes during the whole period of treatment (data not shown). 
 
Down-Regulation of p53 with Its Antisense Oligonucleotides on AGS-Induced Apoptosis 
The role of p53 in AGS-induced apoptosis was confirmed by using various concentrations of 
antisense oligonucleotides. The phosphorothioate antisense oligonucleotide for p53 and the 
control CG-matched randomized-sequence phosphorothioate oligonucleotides were purchased 
from Biognostik (GÖttingen, FRG). Cells growing in log phase were seeded in 24-well plates 
at a density of 1×105 cells per well. In order to enhance the uptake of oligonucleotide, we pre-
incubated 0.8μl oligos with lipofectin (5 μg/ml, Life technologies, Gaithersburg, MD, USA) 
for 30 minutes, then add to cultured cells and incubate for another 30 minutes. After washing, 
supplemented medium containing 5μM oligos were added for 18 hours. Then As2O3 (1 μM) 
was added to the culture medium for a fixed time period for further analysis. Figure 5 showed 
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that 5 μM p53 antisense oligonucleotide could effectively inhibit the As2O3-induced increase 
in p53 protein level after 12 hours, whereas the control oligonucleotide showed no effect on 
p53 expression. The p53 antisense oligonucleotide also inhibited the As2O3-induced apoptosis. 
At 1 μM of As2O3, the percentage of apoptotic cells decreased from 29.5% ± 2.3% to 8.9% ± 
1.4% by the addition of 5 μM of p53 antisense oligonucleotide (p<0.05). The same 
concentration of control oligonucleotide showed no effect on apoptosis induced by As2O3 
(Figure 6).  
 
Effect of As2O3 in activation of caspase 3 and cleavage of poly (ADP-ribose) polymerase 
(PARP)  
Caspases, especially caspase 3 (CPP-32), have been shown to participate in apoptosis. To see 
if apoptosis induced by As2O3 was regulated by caspase 3, we examined several aspects of the 
caspase 3 activation. In the first experiment, different concentrations of As2O3 were added to 
AGS cells for 0, 3, 6, 12, 24 and 48 hours. After treatment, caspase 3 protease activity was 
assessed in cell lysates by measuring hydrolysis of colorimetric caspase 3 substrate DEVD-
ρNA. Figure 7 illustrated the time course of caspase 3 protease activity in AGS cells after 
treatment with 1 μM As2O3. Caspase 3 activity began to increase after 3 hours and reached a 
maximal level after 24 hours in a linear fashion. In the next experiment, the expression of 
caspase 3 during apoptosis was studied by Western blot analysis. The 32 kD procaspase 3, 
when activated, was cleaved into two subunits of 17 and 12 kD assembled into enzymatically 
active heterotetramers as shown in Figure 8A. The amount of proenzyme decreased with the 
appearance of the 17 kD active form with increasing concentration of As2O3, in parallel with 
the degree of apoptosis. To further confirm the involvement of caspase 3 in As2O3-induced 
apoptosis, we took advantage of the general property of the caspase family of leading to the 
specific cleavage of certain substrates during apoptosis, such as poly (ADP-ribose) 
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polymerase (PARP). An anti-PARP antibody capable of detecting both the uncleaved 116 kD 
proform and the active cleaved 85 kD fragments of PARP was used in Western blotting. The 
85 kD fragment cleaved from the 116 kD PARP was detected in extracts from AGS cells 
treated with As2O3 at concentrations of 1 μM and 10 μM after 24 hours (Figure 8B). Both 
caspase 3 activation and PARP cleavage followed a concentration-dependent manner, which 
were in parallel with the induction of apoptosis. 
 
Caspase inhibitors suppressed As2O3-induced caspase 3 activation and apoptosis 
Although caspase activation and proteolysis are hallmarks of apoptosis, inhibition of caspases 
does not always prevent cells from undergoing apoptosis, suggesting the existence of caspase-
independent pathway. To confirm the essential role of caspase 3 in As2O3-induced apoptosis, 
we next analyzed the effect of a pan-inhibitor of the caspase family, zVAD-fmk, and a 
specific inhibitor for caspase 3, DEVD-fmk, on apoptosis. We first determined the 
concentration of zVAD-fmk and DEVD-fmk required to inhibit caspase 3 activity. For this, 
we studied the inhibition by zVAD-fmk and DEVD-fmk of the proteolytic cleavage of 
caspase 3 induced by As2O3 in AGS cells. As shown in Figure 9, the cleavage of caspase 3 
was completely blocked by 100 μM zVAD-fmk and 100 μM DEVD-fmk. At this 
concentration, both zVAD-fmk and DEVD-fmk suppressed As2O3–induced apoptosis (Figure 
10).  





Since the first observation of the relationship between arsenic and skin cancer in the 
1820’s, arsenic compounds have been generally accepted as a potent environmental 
carcinogen, more likely as a comutagen and cocarcinogen for human skin and lung cancers 
(Bishop C et al, 1978). However, at a low concentration, some arsenic compounds have 
beneficial effects, such as the stimulation of human hematopoiesis. The use of arsenic 
compounds as therapeutic drug has a long history in traditional Chinese medicine. Recently 
arsenic trioxide (As2O3) induced clinical remission in all-trans-retinoic acid-resistant APL 
patients. (Shen ZX et al, 1997) The plasma concentration of As2O3 was sustained at 1-2 μM, 
regarded as a therapeutic and cancer-selective range in treating APL patients with minimal 
toxicity. The mechanism of action of arsenic trioxide was shown to be the induction of 
apoptosis (Shen ZX et al, 1997). Subsequently a lot of tumors have been tested and the 
apoptosis-inducing effects were more profound in bladder cancer, APL and gastrointestinal 
cancer cells, including the human gastric cancer cell line MGC-803 (Zheng J et al, 1999; 
Penninger JM et al, 1998). 
In the present study, we have shown that As2O3 inhibited the growth and induced apoptosis in 
gastric cancer cells in a time- and concentration-dependent manner. AGS cells bearing wild-
type p53 gene were more sensitive to the growth inhibitory effect of As2O3 than MKN-28 
cells with mutant p53. Similarly, As2O3-induced apoptosis occurred more readily in AGS than 
in MKN-28 cells. We have also shown that As2O3 upregulated p53 expression at the protein 
level only in AGS cells, which contributed to the induction of apoptosis. This finding agrees 
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with previous study showing that sodium arsenate induced an increase in p53 protein level 
which might be activated in response to DNA damage (Salazar AM et al, 1997). The tumor 
suppressor gene p53 is an essential mediator of the cellular response to DNA damage in 
mammalian cells. Both G1 cell cycle arrest (Kastan,MB et al,1991) and apoptosis (Clarke,AR 
et al,1993; Lowe,SW et al,1993) after DNA damage were shown to depend on normal p53 
function (Bates, S et al,1996). The exact mediators of apoptosis after p53 activation are not 
known. Müller M et al showed that wt p53 bound to and transactivated the CD95 gene, 
whereas mt p53 failed to induce apoptosis via activation of the CD95 gene (Müller, M et al, 
1998). In our experiment, the role of p53 was further confirmed by using p53 antisense 
oligonucleotide, which significantly suppressed the As2O3- induced apoptosis in AGS cells. 
Thus, the reduced sensitivity to growth inhibition and apoptosis induction in MKN-28 cells 
compared to AGS cells may be in part explained by the effect of p53 mutation. Some clinical 
studies indicated a trend for association between wtp53 status and sensitivity to chemotherapy 
(Tetu, B  et al, 1998). Our results showed that p53 status in human gastric cancer cells might 
contribute to the sensitivity to cancer treatment, mainly in the readiness to undergo apoptosis. 
Furthermore, we suggest a p53-independent pathway might exist in As2O3- induced apoptosis 
in MKN-28 cells. 
   
 We showed no changes in the expression of p21waf1/cip1, as well as cell cycle phase 
distribution. Similar results have been reported for myeloid leukemia S6 cells and hepatoma 
HepG2 cells, where the induction of wild type p53 failed to arrest cell growth during 
apoptosis (Youish-Rouach E et al, 1993; Jiang MC et al, 1996). The role of p21waf1/cip1 in 
arsenic-induced apoptosis was only reported in PCI-1 cell line in which the increased protein 
level of p21waf1/cip1 was accompanied by G2/M arrest and reduction of cdc2 kinase activity 
(Seol JG et al, 1999). Increased p21waf1/cip1 expression has been correlated with both apoptosis 
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and cell survival, indicating that its role is cell type specific (Sheikh MS et al, 1995; 
Kobayashi T et al, 1995). Our previous studies on AGS cells suggested that overexpression of 
p21waf1/cip1 enhanced cell survival and protected against indomethacin-induced apoptosis (Zhu 
GH et al, 2000). This suggests that the effect of arsenic on p21waf1/cip1 expression and 
involvement in apoptosis is cell type specific.  
   We have shown that As2O3-induced apoptosis was controlled through caspase activation, 
especially caspase 3. Caspase 3 or CPP32 is one of the important candidates for cell death-
inducing proteases that cleave PARP and other vital proteins (Patel T et al, 1996). Recently, it 
was reported that caspase 3 was involved in As2O3-induced apoptosis in APL, B-cell leukemia 
cell lines and neuroblastoma cell lines (Soignet SL et al, 1998; Akao Y et al, 1998; Akao Y et 
al, 1999).  In this study, As2O3 induced caspase 3 activation and PARP cleavage in parallel 
with the induction of apoptosis. Furthermore, caspase inhibitors could effectively block the 
cleavage of caspase 3. However, both zVAD-fmk and DEVD-fmk could only partially inhibit 
As2O3-induced apoptosis in AGS cells. These results indicated that the activation of caspase 3 
was involved in arsenic-induced apoptosis. But it is likely that As2O3 could also induce 
apoptosis partly via a caspase-independent pathway. 
      As2O3 has been intensively investigated as a new treatment for cancer. It has become 
apparent that the mechanism of action of As2O3 is closely related to its ability to induce 
apoptosis. Recent studies showed that As2O3 produced a preferential vascular shutdown in a 
fibrosarcoma animal model, leading to massive necrosis of the tumor, while normal skin, 
muscle and kidney were relatively unaffected (Lew YS et al, 1999). Our study and others 
have shown that gastric cancer cells were more sensitive to As2O3 than other tumors. The 
potential use of As2O3 in treatment of gastric cancer is worth further exploration.  





We are grateful to Mr. KH Ho at the Department of Pathology, the University of Hong Kong 
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Legend 
Figure 1. Effect of As2O3 treatment on the morphology of AGS cells. Cells were treated with 
1μM As2O3 for 24 hours, stained with acridine orange, and analyzed under fluorescence 
microscope. (A) Control, (B) treated with As2O3. 
 
Figure 2. Induction of DNA fragmentation by As2O3 treatment. AGS cells were exposed to 
As2O3 and the formation of DNA fragmentation was determined by agarose gel 
electrophoresis. M, DNA marker; Lane 1, 10μM As2O3; Lane 2, 1μM As2O3; Lane 3, 0.1 μM 
As2O3; Lane 4, control. 
 
Figure 3. The results of FACS analysis of AGS cells treated with As2O3. Cells were treated 
with As2O3 for 24 hours and their DNA content was determined by FACS, as described in 
Materials and Methods. (A) Control (B) 10μM As2O3. 
 
Figure 4. The expression of p53, p21waf1/cip1, c-myc, bcl-2 and bax protein in AGS cells 
treated by As2O3. (A) AGS cells were exposed to 1μM As2O3 for different intervals (0, 4, 8, 
12, 24, 48 hours). The protein levels of p53, p21waf1/cip1, c-myc, bcl-2 and bax were 
determined by Western blotting. Each blot is the representative of three similar experiments.  
 
Figure 5. Effect of oligonucleotides on p53 protein expression. AGS cells were cultured with 
antisense or control oligonucleotide (5 μM) for 18 hours before incubation with 1μM As2O3 
for another 24 hours, after which cell lysates were collected and p53 protein was determined 
by Western blotting. Lane 1, control; Lane 2, 1 μM As2O3 for 12 hours; Lane 3, 1 μM As2O3 
+ 5 μM control oligos for 12 hours; Lane 4, 1 μM As2O3 + 5 μM antisense oligos for 12 
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hours; Lane 5, 1 μM As2O3 for 24 hours; Lane 6, 1 μM As2O3 + 5 μM control oligos for 24 
hours; Lane 7, 1μM As2O3 + 5 μM antisense oligos for 24 hours. This experiment was 
repeated three times and one representative result is shown in this figure.  
 
Figure 6. Suppression of As2O3-induced apoptosis by p53 antisense oligonucleotides. AGS 
cells were pretreated with 5 μM control oligos or anti-sense oligos for 18 hours followed by 1 
μM As2O3 for 48 hours. The percentage of apoptotic cells was measured by acridine orange 
staining. The results are expressed as mean + SE from three different experiments.   *, 
P<0.05 Vs untreated control;  **, p<0.05 Vs As2O3 alone. 
 
Figure 7. Effect of As2O3 on caspase 3 activity in AGS cells. AGS cells were treated with 1 
μM As2O3 for 0, 3, 6, 12, 24 and 48 hours. Protease activity at each time point was assessed 
against the substrate DEVD-ρNA. The data are expressed as the mean ± SD of three different 
experiments.  
 
Figure 8.  Effect of As2O3 on caspase 3 and PARP expression in AGS cells. Cells were 
treated with 0.1, 1, and 10 μM As2O3 for 24 hours. Caspase 3 expression and PARP cleavage 
were analyzed by Western blotting with specific antibodies. (A) Caspase 3; (B) PARP. This 
experiment was repeated three times and one representative result is shown in this figure.   
 
Figure 9. Inhibition of caspase 3 expression and cleavage in As2O3-treated AGS cells by 
specific caspase inhibitors. Cells were cultured for 24 hours in the absence (-) or presence of 
1μM As2O3 and 100 μM zVAD-fmk or 100 μM DEVD-fmk. The expression and cleavage of 
caspase 3 was determined by immunoblotting. This experiment was repeated three times and 
one representative result is shown in this figure.  
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Figure 10. Effect of caspase inhibitors on As2O3-induced apoptosis in AGS cells. Cells were 
pretreated with 100 μM zVAD-fmk or 100 μM DEVD-fmk for 12 hours and followed by 1 
μM As2O3 for another 24 hours. The percentage of apoptosis was determined by acridine 
orange staining. The results are expressed as mean + SE from three different experiments.  
Jiang – 28     





Jiang – 29     
Figure 2 
 


























Jiang – 34     
Figure 9 
 
